Amneal Pharmaceuticals, Inc. AMRX Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s other intangible assets—net?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other intangible assets—net of $534.87M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s other intangible assets—net changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other intangible assets—net decreased by 22.4% year-over-year, from $689.14M to $534.87M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other intangible assets—net?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s other intangible assets—net has grown at a -15.5% compound annual growth rate (CAGR), from $1.3B to $563.5M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.